Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq analysis of STAT1-WT and STAT1-K193R gastric cancer cells

ABSTRACT: This dataset presents ChIP-seq profiles of STAT1 wild-type (STAT1-WT) and lactylation-deficient mutant (STAT1-K193R) in MGC803 gastric cancer cells. The study aims to investigate the impact of STAT1-K193 lactylation on chromatin binding patterns. Comparative analysis of STAT1 occupancy between the two cell lines provides insights into the regulatory roles of STAT1 post-translational modification in gastric cancer progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE300398 | GEO | 2025/07/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Quantitative proteomic analysis using 4D-FastDIA in gastric cancer cells before and after loss-of-function mutation of STAT1-K193 lactylation.

Project description:In this study, we identified a significant lactylation modification at lysine 193 (K193) of STAT1 in gastric cancer tissues through an integrated proteomic and lysine lactylome analysis. Functional assays revealed that the loss of STAT1-K193 lactylation (STAT1-K193la) markedly suppresses gastric cancer cell proliferation, invasion, and metastatic potential. To further elucidate the downstream mechanisms mediated by STAT1-K193 lactylation, we aim to perform comparative proteomic profiling between wild-type STAT1 and the K193 lactylation-deficient mutant. This approach will help identify candidate effector proteins or signaling pathways regulated by STAT1-K193la, which will be subjected to further functional and mechanistic validation to better understand their roles in gastric tumor progression.

2025-09-05 | PXD065104 | Pride

ChIP-seq analysis of STAT1-WT and STAT1-K193R gastric cancer cells

Project description:ChIP-seq analysis of STAT1-WT and STAT1-K193R gastric cancer cells

| PRJNA1280889 | ENA

Down-regulation of FABP5 suppresses the proliferation and induces apoptosis in gastric cancer cells through Hippo signaling pathway

Project description:We used RNA-seq to study the function of FABP5 in gastric cancer cells (AGS and MGC803). Down-regulation of FABP5 suppressed cell proliferation, cell migration and invasion, and induced cell apoptosis. Bioinformatics analysis revealed that Hippo signaling pathway was related to FABP5 in GC cells.Our data suggested that FABP5 might act as a potential target associated with Hippo signaling pathway for GC treatment.

2022-12-31 | GSE171838 | GEO

RNA-seq and CUT&Tag analysis of the effects of lncRNA LOC105378662 knockdown in gastric cancer cells

Project description:To elucidate whether lncRNA LOC105378662 plays a role in gastric cancer tumorigenesis, a RNA-seq analysis was performed to compare the gene expression profiles of LOC105378662 siRNA and control siRNA transfectants. And we found LOC105378662 interact with BRD7 ( bromodomain containing 7), which usually acted as a co-factor in gene transcription. Therefore, we compared the enrichment of BRD7 in MGC803 cells with LOC105378662 siRNA and control siRNA transfectants through CUT&Tag sequencing.

2024-11-24 | GSE189471 | GEO

Vicious circle of LSD1 and TGF Î²1 promotes EMT of gastric cancer

Project description:Vicious circle of some key proteins is critical in the process of tumor development. Nevertheless, the mechanism of how the epigenetic modifiers are involved in was seldom reported and has not been clearly illustrated. We found the expression of lysine specific demethylase 1 (LSD1), the first identified histone lysine demethylase, is positively correlated with transforming growth factor beta 1 (TGF Î²1) in gastric cancer tissues and can be promoted by TGF Î²1 activated (p-EKR)-(NF-ÎºB)-p300 signaling pathway, which resulted in the progression of epithelial-mesenchymal transition (EMT) in human gastric cancer cells. On the other hand, abrogation of LSD1 leads to the down regulation of TGF Î²1 as well as the EMT. But in benign cells, this circle was blocked by TGF Î²1 induced inactivation of ERK, which suggested the distinct roles of TGF Î²1 against LSD1 in gastric cancer cells and benign cells. This vicious cycle may illustrate a novel mechanism for EMT in gastric cancer mediate by TGF Î²1 and LSD1 but not in benign cells and may serve as a new strategy for the prevention of EMT for gastric cancer. Nuclear extracts prepared from MGC803 cells stably expressing Lenti-CAS9-sgRNA-puro for LSD1 or empty vector were used in immunoprecipitation reactions with antibodies against H3K4me2 and H3K9me2. Sequencing libraries were prepared using the TruSeq DNA Sample Prep Kit (Illumina) and sequencing was performed on a HiSeq2000 (Illumina).

2016-07-19 | E-GEOD-84487 | biostudies-arrayexpress

Spatial transcriptomic analysis of Gastric adenocarcinoma

Project description:This study aims to identify novel cancer stem cell markers by analyzing gastric cancer with spatial transcriptome. This analysis identified a cancer stem cell-associated molecule.

2024-10-16 | GSE245704 | GEO

Identification of lysine-lactylated substrates in gastric cancer cells

Project description:Lysine lactylation is a newly discovered post-translational modification (PTM) in histones and plays important roles in regulating gene expression. However, Kla in non-histone proteins in mammal is still unclear. Here, an analysis of lactylated proteins in gastric cancer AGS cells by using LC-MS/MS was conducted, and 2375 Kla sites on 1014 proteins were identified.

2022-08-11 | PXD033991 | Pride

Identification of downstream target genes of NR2F1 in gastric cancer

Project description:This study aims to identify the downstream target genes of NR2F1 in gastric cancer.

2023-09-30 | GSE233167 | GEO

Discovery of gastric cancer-specific biomarkers by the application of serum proteomics

Project description:The aims of this study are to compare the proteomes of serum samples from patients with gastric cancers and normal controls, and to develop useful tumor markers of gastric cancer by quantitative proteomic analysis

2017-02-08 | PXD005156 | Pride

ErbB2 Glycomic Data from WT and ST6GAL1 K.O. Gastric Cancer Cells

Project description:Glycomic analysis of total N-glycan species released from ErbB2 isolated from WT and ST6GAL1 K.O. ErbB2-positive gastric cancer cells (NCI-N87)

2020-02-11 | MSV000084943 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data